JP2003504312A - 生物学的に活性な材料 - Google Patents

生物学的に活性な材料

Info

Publication number
JP2003504312A
JP2003504312A JP2001504417A JP2001504417A JP2003504312A JP 2003504312 A JP2003504312 A JP 2003504312A JP 2001504417 A JP2001504417 A JP 2001504417A JP 2001504417 A JP2001504417 A JP 2001504417A JP 2003504312 A JP2003504312 A JP 2003504312A
Authority
JP
Japan
Prior art keywords
dextrin
polymer
drug conjugate
mol
polymeric drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001504417A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003504312A5 (enExample
Inventor
ルース ダンカン，
デイル フレツク−ハースト，
リサ ジャーマン，
Original Assignee
エムエル ラボラトリーズ ピーエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914187.1A external-priority patent/GB9914187D0/en
Priority claimed from GBGB9930252.3A external-priority patent/GB9930252D0/en
Application filed by エムエル ラボラトリーズ ピーエルシー filed Critical エムエル ラボラトリーズ ピーエルシー
Publication of JP2003504312A publication Critical patent/JP2003504312A/ja
Publication of JP2003504312A5 publication Critical patent/JP2003504312A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2001504417A 1999-06-18 2000-06-19 生物学的に活性な材料 Pending JP2003504312A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9914187.1 1999-06-18
GBGB9914187.1A GB9914187D0 (en) 1999-06-18 1999-06-18 Biologically active materials
GB9930252.3 1999-12-22
GBGB9930252.3A GB9930252D0 (en) 1999-12-22 1999-12-22 Biologically active molecules
PCT/GB2000/002216 WO2000078355A2 (en) 1999-06-18 2000-06-19 Biologically active materials

Publications (2)

Publication Number Publication Date
JP2003504312A true JP2003504312A (ja) 2003-02-04
JP2003504312A5 JP2003504312A5 (enExample) 2007-07-26

Family

ID=26315678

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001504417A Pending JP2003504312A (ja) 1999-06-18 2000-06-19 生物学的に活性な材料

Country Status (11)

Country Link
US (1) US6818630B1 (enExample)
EP (1) EP1198253A2 (enExample)
JP (1) JP2003504312A (enExample)
AU (1) AU783886B2 (enExample)
CA (1) CA2374548A1 (enExample)
HK (1) HK1047884A1 (enExample)
IL (1) IL146795A0 (enExample)
MX (1) MXPA01013276A (enExample)
NO (1) NO20016147L (enExample)
NZ (1) NZ515999A (enExample)
WO (1) WO2000078355A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
WO2002020663A2 (en) 2000-09-06 2002-03-14 Ap Pharma, Inc. Degradable polyacetal polymers
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
DE10129369C1 (de) 2001-06-21 2003-03-06 Fresenius Kabi De Gmbh Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats
DE60323936D1 (de) 2002-01-14 2008-11-20 Gen Hospital Corp Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
US8030459B2 (en) 2002-07-19 2011-10-04 The General Hospital Corporation Oxime conjugates and methods for their formation and use
DE60323756D1 (de) 2002-10-08 2008-11-06 Fresenius Kabi De Gmbh Pharmazeutisch aktive oligosaccharid-conjugate
US7947261B2 (en) * 2003-05-23 2011-05-24 Nektar Therapeutics Conjugates formed from polymer derivatives having particular atom arrangements
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
DE602004032553D1 (de) * 2003-09-05 2011-06-16 Gen Hospital Corp Polyacetal-arzneimittelkonjugate als freisetzungssystem
PA8853201A1 (es) 2008-12-10 2010-07-27 Mersana Therapeutics Inc Formulaciones farmaceuticas de conjugados de camtotecina-polimero biocompatibles biodegradables
KR102366322B1 (ko) 2020-07-31 2022-02-22 주식회사 다산네트웍스 전기자전거 주행시스템

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477931A1 (en) * 1990-09-28 1992-04-01 Mercian Corporation Novel adriamycin derivatives
WO1998056424A1 (en) * 1997-06-12 1998-12-17 Ml Laboratories Plc Biologically active materials

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005199A1 (en) * 1993-08-19 1995-02-23 Dextran Products Limited Pharmaceutical preparation and a process for making same
IT1281877B1 (it) 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477931A1 (en) * 1990-09-28 1992-04-01 Mercian Corporation Novel adriamycin derivatives
WO1998056424A1 (en) * 1997-06-12 1998-12-17 Ml Laboratories Plc Biologically active materials

Also Published As

Publication number Publication date
NZ515999A (en) 2004-03-26
AU5413000A (en) 2001-01-09
HK1047884A1 (zh) 2003-03-14
AU783886B2 (en) 2005-12-22
CA2374548A1 (en) 2000-12-28
NO20016147L (no) 2002-01-29
NO20016147D0 (no) 2001-12-17
WO2000078355A3 (en) 2002-02-21
EP1198253A2 (en) 2002-04-24
US6818630B1 (en) 2004-11-16
IL146795A0 (en) 2002-07-25
MXPA01013276A (es) 2002-06-04
WO2000078355A2 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
US7186413B2 (en) Hydrogels and water soluble polymeric carriers for drug delivery
Duncan Development of HPMA copolymer–anticancer conjugates: clinical experience and lessons learnt
Kostka et al. HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours
US6822086B1 (en) Drug-carrier complexes and methods of use thereof
US20020155992A1 (en) Poly (dipeptide) as a drug carrier
US20040077595A1 (en) Cyclodextrin-based polymers for therapeutics delivery
JP2014111657A (ja) 放出システムとしてのポリアセタール薬物抱合体
EP2063914B1 (en) Grafted macromolecular conjugates of doxorubicin with anticancer activity and method of their preparation
EP1206252A1 (en) Amplification of folate-mediated targeting to tumor cells using polymers
Howard et al. Polymer micelles with hydrazone-ester dual linkers for tunable release of dexamethasone
JP2003504312A (ja) 生物学的に活性な材料
US6338843B1 (en) Biologically active materials
CN1694728B (zh) 用于传递治疗剂的以环糊精为基础的聚合物
CA2397781A1 (en) Compositions with enhanced oral bioavailability
US20040121954A1 (en) Poly(dipeptide) as a drug carrier
CA2443052A1 (en) Use of cationic dextran derivatives for protecting dose-limiting organs
CN102652836A (zh) 靶向释药的抗癌蛋白质或多肽聚合物前药及其制备方法
AU2002246164A1 (en) Use of cationic dextran derivatives for protecting dose-limiting organs

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070608

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070608

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20101013

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101021

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110705